Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 7/20 | 0.54 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.54 |
| ▸ | HTR3B | O95264 | 1/20 | 0.54 |
| ▸ | HTR3A | P46098 | 1/20 | 0.54 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.54 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.54 |
| ▸ | ADORA2A | P29274 | 9/20 | 0.49 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL169235 | 1.00 | MAPK8 (0.54) | MAPK8HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL25299727 | 0.86 | ADORA2A (0.53) | MAPK8HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL30578099 | 0.79 | MAPK8 (0.54) | MAPK8HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL120846 | 0.79 | MAPK8 (0.54) | MAPK8HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL13131265 | 0.79 | PTPN2 (0.59) | MAPK8HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL8110850 | 0.79 | MAPK8 (0.64) | MAPK8HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL11495421 | 0.79 | RAD51 (0.65) | MAPK8HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL29138850 | 0.78 | IKBKB (0.36) | MAPK8HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL11417540 | 0.77 | MAPK8 (0.55) | MAPK8HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL2947748 | 0.76 | MAPK8 (0.53) | MAPK8HTR3EHTR3BHTR3AHTR3D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4667460-A1 | MIR-124 INDUCER, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Nanjing Synnocare Pharmaceutical Technology Co., Ltd. (CN) | 2025-12-24 | — | — | EP | disclosed |